Biology teacher becomes first UK patient to receive ‘gamechanger’ therapy for MS

Biology teacher becomes first UK patient to receive ‘gamechanger’ therapy for MS

Emily Henders, 37, received her CAR T-cell therapy last week and hopes it will slow down or halt progression of her MS. A biology teacher has become the first patient in the UK to receive a “gamechanger” therapy to treat multiple sclerosis (MS). The CAR T-cell treatment, which experts believe could “transform” lives by halting or slowing down progression of the disease, is custom-built for each patient in the lab. The person’s own T cells, which…

Hertfordshire mum is first UK patient to trial new MS treatment | Tech, Entertainment, Sport, Fashion, Travel News

Louise ParryBedfordshire, Hertfordshire and Buckinghamshire Lucy North/PA Media Emily Henders is taking part in a trial of T-cell therapy, which has proved successful in treating blood cancer A biology teacher and mother-of-two has become the first UK patient to receive a “gamechanger” therapy to treat multiple sclerosis (MS). Emily Henders, 37, from Bushey, Hertfordshire, was treated at University College London Hospital (UCLH) as part of a g…

Hertfordshire mum is first UK patient to trial new MS treatment

Lucy North/PA Media Emily Henders is taking part in a trial of T-cell therapy, which has proved successful in treating blood cancer A biology teacher and mother-of-two has become the first UK patient to receive a “gamechanger” therapy to treat multiple sclerosis (MS). Emily Henders, 37, from Bushey, Hertfordshire, was treated at University College London […] The post Hertfordshire mum is first UK patient to trial new MS treatment first appeared …

Teacher becomes first UK patient to receive ‘gamechanger’ therapy for MS

Sign up for our free Health Check email to receive exclusive analysis on the week in healthGet our free Health Check emailGet our free Health Check emailA biology teacher has been given a “gamechanger” therapy to treat multiple sclerosis (MS), becoming the first patient in the UK to receive the procedure.Experts believe the CAR T-cell